TVARDI THERAPEUTICS, INC. Severance Costs
TVARDI THERAPEUTICS, INC. (TVRD) reported Severance Costs of $5.69 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2025-03-11
- TVARDI THERAPEUTICS, INC. severance costs for the quarter ending 2024-12-31 was $0.00.
- TVARDI THERAPEUTICS, INC. severance costs for the quarter ending 2024-09-30 was $707.00K.
- TVARDI THERAPEUTICS, INC. severance costs for the quarter ending 2024-06-30 was $2.58M.
- TVARDI THERAPEUTICS, INC. severance costs for the quarter ending 2024-03-31 was $2.40M.
- TVARDI THERAPEUTICS, INC. severance costs for fiscal 2024 was $5.69M.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2025-03-11 | $707.00K derived: sum of 2 quarters · filed 2025-03-11 | $3.29M derived: sum of 3 quarters · filed 2025-03-11 | $5.69M 10-K · filed 2025-03-11 |
| 2024-09-30 | $707.00K 10-K · filed 2025-03-11 | $3.29M derived: sum of 2 quarters · filed 2025-03-11 | $5.69M derived: sum of 3 quarters · filed 2025-03-11 | |
| 2024-06-30 | $2.58M 10-K · filed 2025-03-11 | $4.98M derived: sum of 2 quarters · filed 2025-03-11 | ||
| 2024-03-31 | $2.40M 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |